How many institutions held MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value in Q4 2022?

55 institutional investors reported MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value for Q4 2022. Use the holders table for investor-level position and value details.

Milestone Pharmaceuticals Inc. - Common Shares, no par value (MIST)

Q: What does CUSIP 59935V107 represent in this 13F holders report?

CUSIP 59935V107 is the security identifier for MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value used to aggregate holder disclosures.

CUSIP: 59935V107

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common Shares, no par value
Total 13F shares: 23,737,827
Total 13F value: $94,006,246
Share change: +1,996,393
Put/Call ratio: 2.1%
SEC-reported price per share: $3.96
Number of holders: 55
Value change: -$28,853,317
Number of buys: 39
Number of sells: 19
Shares outstanding: 124,217,096

Security key

59935V107

Report period

Q4 2022

Institutions

Top holders

MIST full security history Ownership snapshot Full 13F holder table Milestone Pharmaceuticals Inc. SEC filings Milestone Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RTW INVESTMENTS, LP

Disclosed value leader

RTW INVESTMENTS, LP

Comparable rows

15/15

Latest evidence

30 Sep 2022

13F Lead comparable stake: 3.5% Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP leads the comparable SEC ownership view at 3.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.

Comparable ownership Top 5

RTW INVESTMENTS, LP 3.5%

Venrock Adviser, LLC 2%

RA CAPITAL MANAGEMENT, L.P. 1.8%

Novo Holdings A/S 1.6%

Lion Point Capital, LP 1.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RTW INVESTMENTS, LP	13F Company 13F	3.5%	$39,656,000 4,315,102 shares	—	30 Sep 2022
Venrock Adviser, LLC	13F Company 13F	2%	$22,293,000 2,425,737 shares	—	30 Sep 2022
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	1.8%	$20,645,000 2,246,503 shares	—	30 Sep 2022
Novo Holdings A/S	13F Company 13F	1.6%	$18,380,000 2,000,000 shares	—	30 Sep 2022
Lion Point Capital, LP	13F Company 13F	1.3%	$11,186,000 1,557,233 shares	—	30 Sep 2022
MORGAN STANLEY	13F Company 13F	1%	$11,398,000 1,240,273 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

23,737,827

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %